Robert Schwartz is a Dermatology physician affiliated with Rutgers New Jersey Medical School. OpenAlex indexes 807 publications with 26,046 citations (h-index 79). By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
185 South Orange Avenue
Msb H-576
Newark, NJ 07103
Telephone
973-972-6255Provider last certified this registry record 24 Jan 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
64.8%Corticosteroid44.4%Triamcinolone Acetonide100%Part D≥99 patientsalpha-Hydroxy Acid16.8%Ammonium Lactate100%Part D≥35 patients+ 1 more class in this area
Anti-infectives
21.4%Azole Antifungal15.6%Ketoconazole100%Part D≥31 patientsLincosamide Antibacterial5.8%Clindamycin Phosphate100%Part D<11 patientsSensory organs
9.2%Corticosteroid9.2%Hydrocortisone100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Genetic Viral and Host Adaptations to Breach Species Barriers of HCV
Princeton University
FY2026$459,652R01AI107301 - Genetic Viral and Host Adaptations to Breach Species Barriers of HCV
Princeton University
FY2026$88,168R01AI107301 - Genetic Viral and Host Adaptations to Breach Species Barriers of HCV
Princeton University
FY2025$531,385R01AI107301
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Generalized pustular psoriasis: a review and update on treatment
Journal of the European Academy of Dermatology and Venereology
2018 - Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review
Journal of the American Academy of Dermatology
2017 - Vitiligo and depression: a systematic review and meta‐analysis of observational studies
British Journal of Dermatology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
David Alland, MD
Rutgers New Jersey Medical School
Jerrold Ellner, MD
Rutgers New Jersey Medical School
David Goldberg, MD
Rutgers New Jersey Medical School
Albert Khouri, MD
Rutgers New Jersey Medical School
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”